Harrow Inc.
Organization details
- Legal name
- Harrow Inc.
- Former names
- Harrow Health, INC. Imprimis Pharmaceuticals, Inc. Transdel Pharmaceuticals Inc Bywater Resources, Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Nashville
- Headquarters state / province
- Tennessee
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HROW
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001360214
- EIN
- 45-0567010
- Wikidata ID
- Q22079529
Board of directors
-
Adrienne L. Graves · DirectorSince 2024
-
Horn R. Lawrence Van · DirectorSince 2023
-
Lauren P. Silvernail · DirectorSince 2024
-
Mark L. Baum · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Martin A. Makary · DirectorSince 2023
-
Perry J. Sternberg · DirectorSince 2023
-
Teresa Sparks · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 18, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.0%
-
98.7%
-
98.8%
-
98.9%
Board connections
3 of this board's directors also sit on 4 other boards. 3 are in the same sector.
- via Horn R. Lawrence Van
-
InnovAge Holding Corp. Same sectorvia Teresa Sparks
-
Ocular Therapeutix Inc. Same sectorvia Adrienne L. Graves
-
Opus Genetics Inc. Same sectorvia Adrienne L. Graves
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $468,720
- 4 purchases by 4 insiders
- Sold, last 12 months
- $9,633,891
- 7 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | Shojaei Amir Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +11,250 | $35.96 | $404,550 |
| Aug 14, 2026 | Shojaei Amir Officer (CHIEF SCIENTIFIC OFFICER) | Open-market sale | −11,250 | $40.00 | $450,000 |
| May 18, 2026 | Adrienne L. Graves Director | Open-market purchase | +1,000 | $31.07 | $31,070 |
| May 18, 2026 | Lauren P. Silvernail Director | Open-market purchase | +1,000 | $31.00 | $31,000 |
| May 14, 2026 | Mark L. Baum Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market purchase | +10,000 | $30.20 | $302,000 |
| May 14, 2026 | BOLL ANDREW R. Officer (PRESIDENT AND CFO) | Open-market purchase | +3,500 | $29.90 | $104,650 |
| Mar 4, 2026 | Opaleye Management Inc. 10% owner | Open-market sale | −134,000 | $39.67 | $5,315,780 |
| Mar 4, 2026 | Opaleye Management Inc. 10% owner | Open-market sale | −4,263 | $39.67 | $169,113 |
| Mar 3, 2026 | Opaleye Management Inc. 10% owner | Open-market sale | −59,000 | $39.15 | $2,309,850 |
| Mar 3, 2026 | Opaleye Management Inc. 10% owner | Open-market sale | −1,309 | $39.15 | $51,247 |
| Feb 27, 2026 | Opaleye Management Inc. 10% owner | Open-market sale | −5,000 | $54.18 | $270,900 |
| Jan 6, 2026 | Opaleye Management Inc. 10% owner | Open-market sale | −20,000 | $53.35 | $1,067,000 |
| Dec 12, 2025 | BOLL ANDREW R. Officer (PRESIDENT AND CFO) | Option exercise | +60,000 | $3.95 | $237,000 |
| Dec 12, 2025 | Mark L. Baum Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise | +180,000 | $3.95 | $711,000 |
| Dec 12, 2025 | BOLL ANDREW R. Officer (PRESIDENT AND CFO) | Shares withheld for tax | −26,665 | $47.06 | $1,254,855 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Harrow Inc.
Who is the CEO of Harrow Inc.?
Mark L. Baum is Harrow Inc.'s Chief Executive Officer.
How many directors are on Harrow Inc.'s board?
Harrow Inc.'s board has 7 directors: Adrienne L. Graves, Horn R. Lawrence Van, Lauren P. Silvernail, Mark L. Baum, Martin A. Makary, Perry J. Sternberg and Teresa Sparks.
Are Harrow Inc. insiders buying or selling shares?
Over the last 12 months, Harrow Inc. insiders bought $468,720 of shares in 4 purchases and sold $9.6 million of shares in 7 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="harrow-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.